In this video from the 2015 ONS meeting, Dr. Sipples talks about effective management of side effects for patients taking afatinib, an oral, targeted agent for lung cancer.

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!

Related Content

Multidisciplinary AE Education Enables Safer Inpatient/Outpatient BiTE Therapy

Ashling Wahner

September 10th 2025

Article

Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.

Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice

Ishmael Applewhite, BSN, RN-BC, OCN;Leslie Bennett, MSN, RN;Kathy Mooney, MSN, RN, ACNS-BC, BMTCN®, OCN®

September 10th 2025

Podcast

patients on the trial expected acupuncture to reduce cancer-related symptoms like pain and fatigue (4.2 ± 0.8), allow them to cope with their cancer (3.9 ± 1.0), decrease emotional distress (3.9 ± 1.0), and prevent future health problems (3.3 ± 1.1).

Social Determinants of Health Affect Acupuncture Expectancy in Breast Cancer

Ariana Pelosci

September 10th 2025

Article

ONS Role in New Guideline for irAE Management

Kelly Brassil, PhD, RN

Post AHSCT Palliative Care Survey Shows Patient Needs, Clinician Perceptions Differ

Do Not Sell My Personal Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777

Practical Management of Adverse Events Associated With Afatinib

Newsletter